Detalles de la búsqueda
1.
Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation.
J Immunol
; 197(6): 2421-33, 2016 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27521339
2.
An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice.
Kidney Int
; 90(3): 525-39, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27262364
3.
Optimized protocols for studying the NLRP3 inflammasome and assessment of potential targets of CP-453,773 in undifferentiated THP1 cells.
J Immunol Methods
; 467: 19-28, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30735689
4.
Corrigendum to "Optimized protocols for studying the NLRP3 inflammasome and assessment of potential targets of CP-453,773 in undifferentiated THP1 cells" [Journal of Immunological Methods 467 (2019) 19-28].
J Immunol Methods
; 468: 67, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30947983
5.
Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.
J Med Chem
; 55(22): 9831-7, 2012 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23095041
Resultados
1 -
5
de 5
1
Próxima >
>>